文献速递眼整形与眼眶神经眼科眼底病与葡萄膜炎

成人组织细胞疾病患者的眼部受累:临床表现与治疗结局

Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes.
PubMed 文献 · Ophthalmology · 2022-08-03

该回顾性图表综述纳入1996年1月1日至2021年7月1日Mayo Clinic的32例成人组织细胞疾病患者,评估眼部、眼眶、视神经或海绵窦受累的临床表现、治疗与结局。69%的患者眼部受累为初诊表现,眼睑水肿和眼球突出最常见;眼眶受累多见于朗格汉斯细胞组织细胞增生症(LCH)和Erdheim-Chester病(ECD),眼部受累多见于Rosai-Dorfman病(RDD)。视力可能因眼部受累或弥漫性眼眶受累压迫视神经而受影响。

要点

  • 32例成人组织细胞疾病患者中,22例(69%)眼部受累为初诊表现。
  • 眼睑水肿(13/32,41%)和眼球突出(12/32,38%)是最常见表现。
  • 眼眶受累多见于LCH和ECD,眼部受累多见于RDD。

核心结论

  • 眼眶受累更常见于LCH和ECD,而眼部受累更常见于RDD。
  • 视力可能因眼部受累或弥漫性眼眶受累压迫视神经而受影响。
  • 患者接受多种治疗,不同疾病类型的治疗反应存在差异。

研究设计与样本

  • 观察性、回顾性图表综述,纳入1996年1月1日至2021年7月1日Mayo Clinic的成人(年龄≥18岁)组织细胞疾病患者。
  • 纳入标准为:经活检确诊组织细胞疾病且临床表型相符;有可用病历记录;有眼部、眼眶、视神经或海绵窦受累。
  • 共纳入32例患者:7例LCH,15例ECD,1例混合LCH/ECD表型,8例RDD,1例混合RDD/ECD表型。

主要发现

  • 眼部受累为初诊表现者占69%(22/32)。
  • 眼睑水肿见于13/32(41%),眼球突出见于12/32(38%)。
  • 孤立性眼眶或海绵窦受累见于3/7例LCH患者和1/8例RDD患者。
  • 视神经鞘受累见于2/7例LCH患者、14/15例ECD患者和1例RDD/ECD患者;弥漫性(>75%)眼眶受累见于12/15例ECD患者和1/7例LCH患者。
  • 眼部受累见于1/15例ECD患者、6/8例RDD患者和1/1例混合RDD/ECD患者;海绵窦受累见于1/7例LCH患者、5/15例ECD患者和两例混合表型患者。视力受影响者14例(14/24,58%),最小分辨角对数视力中位数为0.1(范围,-0.12至3)。BRAF V600E突变见于75%(3/4)的LCH患者和91%(10/11)的ECD患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the clinical presentation, treatment, and outcomes in adult patients with histiocytic disorders with ocular, orbital, optic nerve, or cavernous sinus involvement. DESIGN: Observational, retrospective chart review. PARTICIPANTS: Adult patients (age ≥ 18 years) at Mayo Clinic from January 1, 1996, to July 1, 2021, with histiocytic disorders. Inclusion criteria were (1) histiocytic disorder by biopsy and appropriate clinical phenotype; (2) available medical records; and (3) ocular, orbital, optic nerve, or cavernous sinus involvement. METHODS: Retrospective chart review. MAIN OUTCOME MEASURES: Response to therapy, measured in clinical and radiographic impact. RESULTS: Thirty-two patients were identified: 7 with Langerhans cell histiocytosis (LCH); 15 with Erdheim-Chester disease (ECD); 1 with mixed LCH/ECD phenotype; 8 with Rosai-Dorfman disease (RDD); and 1 with mixed RDD/ECD phenotype. Ophthalmologic involvement was part of the initial presentation in 69% of patients (22/32). Eyelid edema (13/32, 41%) and proptosis (12/32, 38%) were the most frequent presentations. Isolated orbital or cavernous sinus involvement was present in 3 of 7 patients with LCH and 1 of 8 patients with RDD. Optic nerve sheath involvement was present in 2 of 7 LCH patients, 14 of 15 ECD patients, and 1 RDD/ECD patient. Diffuse (> 75%) orbital involvement was seen in 12 of 15 ECD patients and 1 of 7 LCH patients. Ocular involvement was seen in 1 of 15 ECD patients, 6 of 8 RDD patients, and 1 of 1 mixed RDD/ECD patient. The cavernous sinuses were involved in 1 of 7 LCH patients, 5 of 15 ECD patients, and both mixed phenotype patients. Visual acuity was affected in 14 patients (14/24, 58%) with a median logarithm of the minimum angle of resolution visual acuity of 0.1 (range, -0.12 to 3). BRAF V600E mutations were found in 75% (3/4) of LCH patients and 91% (10/11) of ECD patients. Patients received a variety of treatment, and response was variable across disease types. CONCLUSIONS: Orbital involvement was more commonly seen in LCH and ECD, whereas ocular involvement was more common in RDD. Visual acuity may be impacted from ocular involvement or compression of the optic nerve with diffuse orbital involvement.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Banks SA, Bhatti MT, Go RS, et al. Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes. Ophthalmology. 2022. PMID: 35932838. doi:10.1016/j.ophtha.2022.07.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。